Company Quick10K Filing
LCNB
10-Q 2021-03-31 Filed 2021-05-05
10-K 2020-12-31 Filed 2021-03-10
10-Q 2020-09-30 Filed 2020-11-09
10-Q 2020-06-30 Filed 2020-08-06
10-Q 2020-03-31 Filed 2020-05-08
10-K 2019-12-31 Filed 2020-03-04
10-Q 2019-09-30 Filed 2019-11-06
10-Q 2019-06-30 Filed 2019-08-07
10-Q 2019-03-31 Filed 2019-05-08
10-K 2018-12-31 Filed 2019-03-06
10-Q 2018-09-30 Filed 2018-11-09
10-Q 2018-06-30 Filed 2018-08-09
10-Q 2018-03-31 Filed 2018-05-02
10-K 2017-12-31 Filed 2018-03-09
10-Q 2017-09-30 Filed 2017-11-08
10-Q 2017-06-30 Filed 2017-08-08
10-Q 2017-03-31 Filed 2017-05-03
10-K 2016-12-31 Filed 2017-03-08
10-Q 2016-09-30 Filed 2016-11-08
10-Q 2016-06-30 Filed 2016-08-05
10-Q 2016-03-31 Filed 2016-05-04
10-K 2015-12-31 Filed 2016-03-09
10-Q 2015-09-30 Filed 2015-11-04
10-Q 2015-06-30 Filed 2015-08-07
10-Q 2015-03-31 Filed 2015-05-06
10-K 2014-12-31 Filed 2015-03-12
10-Q 2014-09-30 Filed 2014-11-06
10-Q 2014-06-30 Filed 2014-08-06
10-Q 2014-03-31 Filed 2014-05-09
10-K 2013-12-31 Filed 2014-03-06
10-Q 2013-09-30 Filed 2013-11-08
10-Q 2013-06-30 Filed 2013-08-06
10-Q 2013-03-31 Filed 2013-05-09
10-K 2012-12-31 Filed 2013-02-26
10-Q 2012-09-30 Filed 2012-11-06
10-Q 2012-06-30 Filed 2012-08-08
10-Q 2012-03-31 Filed 2012-05-07
10-K 2011-12-31 Filed 2012-02-28
10-Q 2011-09-30 Filed 2011-11-08
10-Q 2011-06-30 Filed 2011-08-09
10-Q 2011-03-31 Filed 2011-05-02
10-K 2010-12-31 Filed 2011-03-01
10-Q 2010-09-30 Filed 2010-11-08
10-Q 2010-06-30 Filed 2010-08-09
10-Q 2010-03-31 Filed 2010-05-03
10-K 2009-12-31 Filed 2010-02-23
8-K 2020-10-20
8-K 2020-08-24
8-K 2020-07-20
8-K 2020-06-10
8-K 2020-04-22
8-K 2020-04-20
8-K 2020-03-04
8-K 2020-01-29
8-K 2019-10-21
8-K 2019-09-20
8-K 2019-08-07
8-K 2019-07-22
8-K 2019-05-30
8-K 2019-05-23
8-K 2019-05-02
8-K 2019-04-24
8-K 2019-04-18
8-K 2019-02-20
8-K 2019-01-29
8-K 2018-12-21
8-K 2018-10-19
8-K 2018-10-18
8-K 2018-10-01
8-K 2018-08-08
8-K 2018-07-19
8-K 2018-06-01
8-K 2018-05-01
8-K 2018-04-25
8-K 2018-04-18
8-K 2018-01-29

LCNB Financials

LCNB Metrics, Comps, Filings

Quarterly | Annual

Valuation ($BB)

Market Cap, Enterprise Value

Balance Sheet ($BB)

Assets, Equity

Income Statement ($BB Quarterly)

Revenue, G Profit, Net Income

Cash Flow ($BB Quarterly)

Ops, Inv, Fin

Comps ($MM TTM) Market Cap Gross Margin EV/EBITDA Ret on Assets Assets Liabilities Revenue G Profit Net Income EBITDA EV
024 Pharma (EEIG)
Bioquest Corp (BQST)
11 Good Energy (ELVN)
BriaCell Therapeutics Corp. (BCTXW)
1347 Capital Corp (TFSC)
DD3 Acquisition Corp. II (DDMXW)
8i Acquisition 2 Corp. (LAX)
Acumen Pharmaceuticals, Inc. (ABOS)
Aerovate Therapeutics, Inc. (AVTE)
Ameren Illinois Co (AILNP)
Frontier Investment Corp (FICV)
Gobi Acquisition Corp. (GOBI)
HEALTH REVENUE ASSURANCE HOLDINGS, INC. (HRAA)
Ocean Biomedical, Inc. (OCEA)
SERA PROGNOSTICS, INC. (SERA)
Xiaoju Kuaizhi Inc. (DIDI)
1PM Industries (OPMZ)
1st Century Bancshares (FCTY)
COMSovereign Holding Corp. (COMSW)
ALABAMA POWER CO (APRCP)

Balance Sheet ($MM)2011-06-302011-09-302011-12-312012-03-312012-06-302012-09-302012-12-312013-03-312013-06-302013-09-302013-12-312014-03-312014-06-302014-09-302014-12-312015-03-312015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-302018-12-312019-03-312019-06-302019-09-30
Cash27332025273313282015263319331618283315211933193330212517252020202323
Accounts Receivable
Inventory
PP&E17171717171732363636363821213820232241222526503335355635333355333334
Assets7938097927928328177899469469429321,1341,1511,1231,1081,1291,2491,2751,2811,2861,3131,3341,3071,3191,3361,3141,2961,2891,6311,6201,6371,6321,6421,644
Accounts Payable
Long-Term Debt21,55315151414131312
Liabilities7197317147137517357078528558508131,0141,0291,0009821,0011,1121,1341,1401,1431,1671,1871,1641,1741,1881,1651,1451,1401,4191,4071,4181,4081,4191,419
Stockholders' Equity74777879808282949092119120123123126129138141140143146147143145148150150149212214219224223225
Income Statement ($MM)2011-06-302011-09-302011-12-312012-03-312012-06-302012-09-302012-12-312013-03-312013-06-302013-09-302013-12-312014-03-312014-06-302014-09-302014-12-312015-03-312015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-302018-12-312019-03-312019-06-302019-09-30
Revenue22211
Cost of Revenue
Gross Profit
R&D
SG&A000000000000000000000000000000000
Tax1161110111101111111111111110011111
Net Income2222222222213333333333433343345555
Cash Flow ($MM)2011-06-302011-09-302011-12-312012-03-312012-06-302012-09-302012-12-312013-03-312013-06-302013-09-302013-12-312014-03-312014-06-302014-09-302014-12-312015-03-312015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-302018-12-312019-03-312019-06-302019-09-30
Cash Operating242333-0434135714452545265155267
Cash Investing-614-382168-15-18-16-3140-4-16-3-19-275-29-1063-1912-44513-3-1
Cash Financing10-18-136-18-2973-7-123313-30-20189205-12219-251010-26-5-2-15-161-6